A Pilot Study to Evaluate Safety and Efficacy of CigRx™ in Smokers
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation, Smoking Cessation, Tobacco Consumers |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 23 - 72 |
| Updated: | 4/21/2016 |
| Start Date: | April 2010 |
| End Date: | April 2010 |
A Randomized, Double-Blind, Active-Controlled, Crossover, Pilot Study to Evaluate the Safety and Efficacy of CigRx™ Lozenge, a Non-Nicotine Non-Tobacco Dietary Supplement, in Daily Smokers in Temporarily Reducing the Desire to Smoke
A randomized, double-blind, active-controlled, crossover, pilot study to evaluate the safety
and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily
reducing the desire to smoke
and efficacy of CigRx™ Lozenge, a dietary supplement, in daily smokers in temporarily
reducing the desire to smoke
Subjects will orally self-administer 2 study products, each in the form of a dissolvable
lozenge, and will complete questionnaires on demographics, urges to smoke, and product
rating.
lozenge, and will complete questionnaires on demographics, urges to smoke, and product
rating.
Inclusion Criteria:
- Healthy adult smokers
- Smoking for at least 5 years
- Smoking at least one (1) pack of cigarettes a day
Exclusion Criteria:
- Allergy to lozenge components
We found this trial at
1
site
Click here to add this to my saved trials
